• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与人类cathelicidin LL-37相关的非溶血性抗菌肽的设计、合成与表征

Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37.

作者信息

Krishnamoorthy Rajavenkatesh, Adhikari Priyanka, Anaikutti Parthiban

机构信息

Organic and Bioorganic Chemistry Laboratory, CSIR-CLRI Adyar Chennai-600020 Tamil Nadu India.

Department of Chemistry, Sethu Institute of Technology Kariapatti Virudunagar-626115 Tamil Nadu India

出版信息

RSC Adv. 2023 May 23;13(23):15594-15605. doi: 10.1039/d3ra02473c. eCollection 2023 May 22.

DOI:10.1039/d3ra02473c
PMID:37228679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10204126/
Abstract

We designed and synthesised the N-terminally labeled cationic and hydrophobic peptides, , FFKKSKEKIGKEFKKIVQKI (P1) and FRRSRERIGREFRRIVQRI (P2) related to the human cathelicidin LL-37 peptide. The integrity and molecular weight of the peptides were confirmed by mass spectrometry. The purity and homogeneity of peptides P1 and P2 were determined by comparing LCMS or analytical HPLC chromatograms. The circular dichroism spectroscopy reveals the conformational transitions upon interaction with membranes. Predictably, peptides P1 and P2 showed a random coil structure in the buffer and formed α-helix secondary structure in TFE and SDS micelles. This assessment was further confirmed by 2D NMR spectroscopic methods. The analytical HPLC binding assay measurements revealed that peptides P1 and P2 display preferential interactions with the anionic lipid bilayer (POPC:POPG) moderately than zwitterionic (POPC). The efficacies of the peptides were tested against Gram-positive and Gram-negative bacteria. It is imperative to note here that the arginine-rich P2 exerted higher activity against all the test organisms as compared with that shown by the lysine-rich peptide P1. To test the toxicity of these peptides, a hemolytic assay was performed. P1 and P2 showed very little to no toxicity for a hemolytic assay, which is significant for P1 and P2 to be used as potential therapeutic agents in practical applications. Both peptides P1 and P2 were non-hemolytic and appeared to be more promising as they demonstrated wide-spectrum antimicrobial activity.

摘要

我们设计并合成了与人类cathelicidin LL-37肽相关的N端标记的阳离子和疏水肽,即FFKKSKEKIGKEFKKIVQKI(P1)和FRRSRERIGREFRRIVQRI(P2)。通过质谱确认了肽的完整性和分子量。通过比较LCMS或分析型HPLC色谱图来测定肽P1和P2的纯度和均一性。圆二色光谱揭示了与膜相互作用时的构象转变。可以预见,肽P1和P2在缓冲液中呈无规卷曲结构,在TFE和SDS胶束中形成α-螺旋二级结构。二维NMR光谱方法进一步证实了这一评估。分析型HPLC结合测定结果表明,肽P1和P2与阴离子脂质双层(POPC:POPG)的优先相互作用比两性离子脂质双层(POPC)更强。测试了这些肽对革兰氏阳性菌和革兰氏阴性菌的功效。必须在此指出的是,与富含赖氨酸的肽P1相比,富含精氨酸的P2对所有测试生物体均表现出更高的活性。为了测试这些肽的毒性,进行了溶血试验。P1和P2在溶血试验中显示出极低的毒性或无毒性,这对于P1和P2在实际应用中作为潜在治疗剂具有重要意义。肽P1和P2均无溶血作用,并且由于它们表现出广谱抗菌活性,因此似乎更具前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/8e51d4f374a3/d3ra02473c-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/65ecde7fed32/d3ra02473c-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/7a6ceda74d02/d3ra02473c-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/412b7409b076/d3ra02473c-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/1cd2912352de/d3ra02473c-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/8f7eb0af704d/d3ra02473c-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/8e51d4f374a3/d3ra02473c-f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/65ecde7fed32/d3ra02473c-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/7a6ceda74d02/d3ra02473c-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/412b7409b076/d3ra02473c-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/1cd2912352de/d3ra02473c-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/8f7eb0af704d/d3ra02473c-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d0de/10204126/8e51d4f374a3/d3ra02473c-f6.jpg

相似文献

1
Design, synthesis, and characterization of non-hemolytic antimicrobial peptides related to human cathelicidin LL-37.与人类cathelicidin LL-37相关的非溶血性抗菌肽的设计、合成与表征
RSC Adv. 2023 May 23;13(23):15594-15605. doi: 10.1039/d3ra02473c. eCollection 2023 May 22.
2
Arginine-Containing Surfactant-Like Peptides: Interaction with Lipid Membranes and Antimicrobial Activity.精氨酸肽:与脂质膜的相互作用和抗菌活性。
Biomacromolecules. 2018 Jul 9;19(7):2782-2794. doi: 10.1021/acs.biomac.8b00391. Epub 2018 May 16.
3
Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37.一种源自人源抗菌肽 LL37 的肽的抗菌和破坏膜活性。
Biophys J. 2010 Jan 20;98(2):248-57. doi: 10.1016/j.bpj.2009.09.060.
4
Characterizing the structure-function relationship reveals the mode of action of a novel antimicrobial peptide, P1, from jumper ant Myrmecia pilosula.表征结构-功能关系揭示了来自多毛牛蚁的一种新型抗菌肽P1的作用模式。
Mol Biosyst. 2017 Jun 1;13(6):1193-1201. doi: 10.1039/c6mb00810k. Epub 2017 May 4.
5
Design and synthesis of novel N-terminal peptides of integrin and aminopeptidase are new finding for anticancer activity.整合素和氨肽酶新型N端肽的设计与合成是抗癌活性方面的新发现。
Bioorg Chem. 2023 May;134:106434. doi: 10.1016/j.bioorg.2023.106434. Epub 2023 Feb 24.
6
Molecular dynamics simulation of the membrane binding and disruption mechanisms by antimicrobial scorpion venom-derived peptides.抗菌蝎毒液衍生肽的膜结合和破坏机制的分子动力学模拟。
J Biomol Struct Dyn. 2018 Jun;36(8):2070-2084. doi: 10.1080/07391102.2017.1341340. Epub 2017 Jun 22.
7
Amphibian Skin Secretions as a Novel Source for the Isolation of Antibacterial Peptides.两栖动物皮肤分泌物作为分离抗菌肽的新型来源。
Molecules. 2018 Nov 11;23(11):2943. doi: 10.3390/molecules23112943.
8
Cationic amphipathic peptide analogs of cathelicidin LL-37 as a probe in the development of antimicrobial/anticancer agents.作为开发抗菌/抗癌药物的探针的抗菌肽 LL-37 的阳离子两亲肽类似物。
J Pept Sci. 2020 Jul;26(7):e3254. doi: 10.1002/psc.3254. Epub 2020 Jun 21.
9
Conformation and Orientation of Antimicrobial Peptides MSI-594 and MSI-594A in a Lipid Membrane.抗菌肽 MSI-594 和 MSI-594A 在脂质膜中的构象和取向。
Langmuir. 2023 Apr 18;39(15):5352-5363. doi: 10.1021/acs.langmuir.2c03430. Epub 2023 Apr 5.
10
Thermodynamics of the interactions of tryptophan-rich cathelicidin antimicrobial peptides with model and natural membranes.富含色氨酸的cathelicidin抗菌肽与模型膜和天然膜相互作用的热力学
Biochim Biophys Acta. 2008 Apr;1778(4):1004-14. doi: 10.1016/j.bbamem.2007.12.022. Epub 2008 Jan 5.

引用本文的文献

1
TC-14, a cathelicidin-derived antimicrobial peptide with broad-spectrum antibacterial activity and high safety profile.TC-14,一种源自cathelicidin的抗菌肽,具有广谱抗菌活性和高安全性。
iScience. 2024 Jun 28;27(7):110404. doi: 10.1016/j.isci.2024.110404. eCollection 2024 Jul 19.

本文引用的文献

1
Conjugation of Ctx(Ile)-Ha Antimicrobial Peptides to Chitosan Ultrathin Films by -Acetylcysteine Improves Peptide Physicochemical Properties and Enhances Biological Activity.通过β-乙酰半胱氨酸将Ctx(Ile)-Ha抗菌肽与壳聚糖超薄膜共轭可改善肽的物理化学性质并增强生物活性。
ACS Omega. 2022 Aug 5;7(32):28238-28247. doi: 10.1021/acsomega.2c02570. eCollection 2022 Aug 16.
2
The Human Cathelicidin Antimicrobial Peptide LL-37 as a Potential Treatment for Polymicrobial Infected Wounds.人源杀菌肽 LL-37 作为一种潜在的多微生物感染伤口治疗方法。
Front Immunol. 2013 Jul 3;4:143. doi: 10.3389/fimmu.2013.00143. eCollection 2013.
3
Transmembrane pores formed by human antimicrobial peptide LL-37.
人抗菌肽 LL-37 形成的跨膜孔。
Biophys J. 2011 Apr 6;100(7):1688-96. doi: 10.1016/j.bpj.2011.02.018.
4
Limiting an antimicrobial peptide to the lipid-water interface enhances its bacterial membrane selectivity: a case study of MSI-367.将一种抗菌肽限制在脂质-水界面可增强其对细菌膜的选择性:以 MSI-367 为例。
Biochemistry. 2010 Dec 21;49(50):10595-605. doi: 10.1021/bi101394r. Epub 2010 Nov 23.
5
Antimicrobial and membrane disrupting activities of a peptide derived from the human cathelicidin antimicrobial peptide LL37.一种源自人源抗菌肽 LL37 的肽的抗菌和破坏膜活性。
Biophys J. 2010 Jan 20;98(2):248-57. doi: 10.1016/j.bpj.2009.09.060.
6
The roles of cathelicidin LL-37 in immune defences and novel clinical applications.抗菌肽LL-37在免疫防御及新型临床应用中的作用
Curr Opin Hematol. 2009 Jan;16(1):41-7. doi: 10.1097/moh.0b013e32831ac517.
7
Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles.人宿主防御阳离子抗菌肽LL-37及其最小抗菌肽KR-12在脂质微团中的结构。
J Biol Chem. 2008 Nov 21;283(47):32637-43. doi: 10.1074/jbc.M805533200. Epub 2008 Sep 25.
8
Nitrogen-14 solid-state NMR spectroscopy of aligned phospholipid bilayers to probe peptide-lipid interaction and oligomerization of membrane associated peptides.采用氮-14固态核磁共振波谱法研究排列有序的磷脂双层,以探测肽与脂质的相互作用以及膜相关肽的寡聚化。
J Am Chem Soc. 2008 Aug 20;130(33):11023-9. doi: 10.1021/ja802210u. Epub 2008 Jul 23.
9
NMR structure of the cathelicidin-derived human antimicrobial peptide LL-37 in dodecylphosphocholine micelles.在十二烷基磷酸胆碱胶束中,人源抗菌肽LL-37(由cathelicidin衍生而来)的核磁共振结构。
Biochemistry. 2008 May 20;47(20):5565-72. doi: 10.1021/bi702036s. Epub 2008 Apr 26.
10
Cholesterol, lanosterol, and ergosterol attenuate the membrane association of LL-37(W27F) and temporin L.胆固醇、羊毛甾醇和麦角固醇会减弱LL-37(W27F)和天蚕抗菌肽L与膜的结合。
Biochim Biophys Acta. 2008 Jun;1778(6):1460-6. doi: 10.1016/j.bbamem.2008.02.014. Epub 2008 Mar 5.